Risk assessment models for thrombosis and anticoagulant-related bleeding in ambulatory cancer patients

M Candeloro, NAM Guman… - … in thrombosis and …, 2021 - thieme-connect.com
Cancer patients have a high risk of developing venous thromboembolism and arterial
thrombosis, along with an increased risk of anticoagulant-related bleeding with primary and …
被引用次数：7 相关文章

Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients

M Candeloro, NAM Guman, N Kraaijpoel… - … IN THROMBOSIS AND …, 2021 - ricerca.unich.it
Cancer patients have a high risk of developing venous thromboembolism and arterial
thrombosis, along with an increased risk of anticoagulant-related bleeding with primary and …

Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients

M Candeloro, NAM Guman… - … in thrombosis and …, 2021 - pubmed.ncbi.nlm.nih.gov
Cancer patients have a high risk of developing venous thromboembolism and arterial
thrombosis, along with an increased risk of anticoagulant-related bleeding with primary and …

Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients

M Candeloro, NAM Guman… - Seminars in …, 2021 - researchinformation.amsterdamumc …
Cancer patients have a high risk of developing venous thromboembolism and arterial
thrombosis, along with an increased risk of anticoagulant-related bleeding with primary and …